Keyphrases
Pancreatic Cancer
100%
Proteomic Analysis
100%
Epithelial-to-mesenchymal Transition
100%
Adenocarcinoma
28%
Tumor Protein p53 (TP53)
14%
Tumor Progression
14%
Pancreatic Metastasis
14%
Metastatic Disease
14%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
14%
Therapeutic Target
14%
Frequent mutation
14%
Genetic Modification
14%
Tumor Metastasis
14%
Growth Factors
14%
Clinical Samples
14%
In-depth Proteomics
14%
Difficult Diagnosis
14%
Genome Complexity
14%
Metastasizing
14%
Cancer Patients
14%
Diagnostic Targets
14%
SMAD4
14%
Tumor Suppressor Gene
14%
KRAS Oncogene
14%
Pancreatic Cancer Cells
14%
Cell Culture
14%
Protein Fractionation
14%
BRCA2
14%
Epithelial Cells
14%
Cellular Fractionation
14%
Pancreatic Cancer Cell Lines
14%
Cancer Stem Cells
14%
Migratory Ability
14%
Pancreatic Cancer Progression
14%
Inducer
14%
Stable Isotope Labeling
14%
Metastatic Process
14%
Medicine and Dentistry
Mesenchymal-Epithelial Transition
100%
Pancreas Cancer
100%
Proteomics
100%
Metastatic Carcinoma
33%
Diagnosis
22%
Adenocarcinoma
22%
Cancer Cell
11%
Cancer Stem Cell
11%
Biological Marker
11%
Tumor Progression
11%
Protein Analysis
11%
Oncogene
11%
BRCA2
11%
Growth Factor
11%
Tumor Suppressor Gene
11%
Pancreatic Cancer Cell Line
11%
Cell Culture
11%
Epithelial Cell
11%
Stable Isotope
11%
Gene Mutation
11%
Cancer Growth
11%
Biochemistry, Genetics and Molecular Biology
Proteomics
100%
Mesenchymal-Epithelial Transition
100%
Cancer Cell
40%
BRCA2
20%
Growth Factor
20%
Tumor Suppressor Gene
20%
Gene Mutation
20%
Genetics
20%
Oncogene
20%
Quantitative Technique
20%
Tumor Progression
20%
Cancer Stem Cell
20%
Cell Culture
20%
KRAS
20%
Isotope Labeling
20%
Fractionation
20%